Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Fact

Re: Fact. PTSC rating stopped - maxandme

in response to by
posted on Feb 04, 2008 07:05AM

maxandme,

I'm not sure where you've been looking but you are not correct about there being no uncompensated analysis of PTSC.

Two analysts featured on Vanguard's site are Reuters and First Call Consensus, which have been following PTSC for some time. Ratings had been an Outperform (highest Reuters rating) and a Strong Buy (highest First Call rating). These are no small time analysts.

First Call, in the last couple of days, stopped rating PTSC: "No First Call ratings data available".

Reuters continues to rate PTSC as Out Perform.

Share
New Message
Please login to post a reply